ACR 2019: Lilly Presents 52-Week Head-to-Head (SPIRIT-H2H) Data from TALTZ® (ixekizumab) Versus Humira® (adalimumab) Trial in Psoriatic Arthritis

NEXT STORY
Enteral Feeding Devices Market To Reach USD 4.07 Billion By 2026 | Reports And Data
PREV STORY
Medical Waste Management Market To Reach USD 17.89 Billion by 2026 | Reports And Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In-Human Trial of RLY-4008

author_avatar
NASDAQ Market News

athenahealth Recognized as Top Practice Management (11-75 Physicians) Service in 2018 KLAS Report

WATERTOWN, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider ...

author_avatar
NASDAQ Market News

Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting

author_avatar
NASDAQ Market News